DRA still affecting GE Healthcare numbers

Financial results were tepid for Chalfont St. Giles, U.K.-based GE Healthcare in the third quarter (end-September 20).

Revenues increased 4% to $4.1 billion, compared with $3.9 billion in the third quarter of 2006. Operating profit slipped to $692 million, compared with $699 million in the same quarter last year.

For the nine-month period, revenues rose to $12 billion, compared with $11.8 billion in the same period of 2006. Operating profit was down 2% to $2.02 billion, from $2.06 billion in the nine-month period of 2006.

While the results were in line with expectations, parent company General Electric of Stamford, CT, noted that GE Healthcare's U.S. imaging business continues to face pressure from effects of the Deficit Reduction Act (DRA) of 2005. In addition, the company's OEC subsidiary has not resumed shipping surgical supplies, as its regulatory suspension continues.

In its third-quarter report, parent company GE added that the balance of the healthcare business "is performing very well."

By AuntMinnie.com staff writers
October 12, 2007

Related Reading

GE expands in PACS with Dynamic Imaging buy, October 11, 2007

GE introduces biopharmaceutical line, October 2, 2007

GE to sell Imtec conebeam CT scanner, September 18, 2007

GE launches pediatric DEXA software, September 17, 2007

GE, NCHL launch institute, August 29, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 3504
Next Page